πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,435 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9145389

Benzimidazole compound crystal

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9139598

Glucokinase activators

Takeda California, Inc. Β· Granted Tue Sep 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9133129

Bicyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9120777

Heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9120776

Condensed heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9115139

Pyrazinooxazepine derivatives

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9115136

Fused ring compound and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9108970

Fused heteroaromatic pyrrolidinones

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9107912

Methods for concomitant treatment of theophylline and febuxostat

Takeda Pharmaceuticals U.S.A., Inc. Β· Granted Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9102744

Conjugated anti-CD38 antibodies

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9102666

Methods and drug products for treating Alzheimer's disease

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9101660

Solid preparation

Takeda Pharmaceutical Company Limited Β· Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9101565

Dissolution stability of calcium carbonate tablets

TAKEDA NYCOMED AS Β· Granted Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9090597

Pyrazolone derivatives as PDE4 inhibitors

TAKEDA GMBH Β· Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9090586

Heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9085578

Heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9079907

Fused heterocyclic compound and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9073918

Pyrazolo[4,3-b]pyridine-7-amine inhibitors of ALK5

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9073864

Aromatic ring compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9066936

Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9060941

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9056873

Substituted 6-aza-isoindolin-1-one derivatives

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9045436

Heterocyclic compound and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9044483

Cell death inhibition by macrophage migration inhibitory factor and a binding substance th

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted